Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Escande

Showing results (701-710 of 760) with videos related to

Pageof 76
Sort By:
Cancer Biomarkers : Section a of Disease Markers|August 12, 2017
Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patientsVéronique Quillien, Audrey Lavenu, François Ducray, et al.
Oncotarget|August 20, 2016
Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trialVéronique Quillien, Audrey Lavenu, François Ducray, et al.
Aging|July 27, 2014
Growth hormone action predicts age-related white adipose tissue dysfunction and senescent cell burden in miceMichael B Stout, Tamara Tchkonia, Tamar Pirtskhalava, et al.
Nature Communications|September 21, 2021
Identification of limb-specific Lmx1b auto-regulatory modules with Nail-patella syndrome pathogenicityEndika Haro, Florence Petit, Charmaine U Pira, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 13, 2024
RPL26 variants: A rare cause of Diamond-Blackfan anemia syndrome with multiple congenital anomalies at the forefrontClémence Vanlerberghe, Frédéric Frénois, Thomas Smol, et al.
Lung Cancer (Amsterdam, Netherlands)|December 17, 2019
Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France projectMichèle Beau-Faller, Erwan Pencreach, Charlotte Leduc, et al.
Gynecologic Oncology|June 28, 2024
Preoperative brachytherapy of early-stage cervical cancer: A multicenter study by the SFRO brachytherapy groupKanta Ka, Abel Cordoba, Leonel Varela Cagetti, et al.
The European Respiratory Journal|August 12, 2017
EGFR tyrosine kinase inhibitors <i>versus</i> chemotherapy in <i>EGFR</i> wild-type pre-treated advanced nonsmall cell lung cancer in daily practicePascale Tomasini, Solenn Brosseau, Julien Mazières, et al.
Scientific Reports|October 9, 2019
A novel form of Deleted in breast cancer 1 (DBC1) lacking the N-terminal domain does not bind SIRT1 and is dynamically regulated in vivoLeonardo Santos, Laura Colman, Paola Contreras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid TumorsLuis Teixeira, Jacques Medioni, Julie Garibal, et al.
Pageof 76

Showing results (701-710 of 760) with videos related to

Sort By:
Pageof 76
Cancer Biomarkers : Section a of Disease Markers|August 12, 2017
Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patientsVéronique Quillien, Audrey Lavenu, François Ducray, et al.
Oncotarget|August 20, 2016
Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trialVéronique Quillien, Audrey Lavenu, François Ducray, et al.
Aging|July 27, 2014
Growth hormone action predicts age-related white adipose tissue dysfunction and senescent cell burden in miceMichael B Stout, Tamara Tchkonia, Tamar Pirtskhalava, et al.
Nature Communications|September 21, 2021
Identification of limb-specific Lmx1b auto-regulatory modules with Nail-patella syndrome pathogenicityEndika Haro, Florence Petit, Charmaine U Pira, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 13, 2024
RPL26 variants: A rare cause of Diamond-Blackfan anemia syndrome with multiple congenital anomalies at the forefrontClémence Vanlerberghe, Frédéric Frénois, Thomas Smol, et al.
Lung Cancer (Amsterdam, Netherlands)|December 17, 2019
Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France projectMichèle Beau-Faller, Erwan Pencreach, Charlotte Leduc, et al.
Gynecologic Oncology|June 28, 2024
Preoperative brachytherapy of early-stage cervical cancer: A multicenter study by the SFRO brachytherapy groupKanta Ka, Abel Cordoba, Leonel Varela Cagetti, et al.
The European Respiratory Journal|August 12, 2017
EGFR tyrosine kinase inhibitors <i>versus</i> chemotherapy in <i>EGFR</i> wild-type pre-treated advanced nonsmall cell lung cancer in daily practicePascale Tomasini, Solenn Brosseau, Julien Mazières, et al.
Scientific Reports|October 9, 2019
A novel form of Deleted in breast cancer 1 (DBC1) lacking the N-terminal domain does not bind SIRT1 and is dynamically regulated in vivoLeonardo Santos, Laura Colman, Paola Contreras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid TumorsLuis Teixeira, Jacques Medioni, Julie Garibal, et al.
Pageof 76